Patient education and self-management

被引：0
作者：
Campbell, R. Keith
Cobble, Michael E.
Reid, Timothy S.
Shomali, Mansur E.
机构：
来源：
JOURNAL OF FAMILY PRACTICE | 2010年 / 59卷 / 09期
关键词：
TYPE-2; DIABETES-MELLITUS; EXENATIDE; LIRAGLUTIDE; GLIMEPIRIDE; METFORMIN;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S28 / S30
页数：3
相关论文
共 15 条
[1]  
[Anonymous], 2009, BYETT PACK INS
[2]  
[Anonymous], JAN PACK INS
[3]  
[Anonymous], 2009, ONGL PACK INS
[4]   Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes [J].
DeFronzo, RA ;
Ratner, RE ;
Han, J ;
Kim, DD ;
Fineman, MS ;
Baron, AD .
DIABETES CARE, 2005, 28 (05) :1092-1100
[5]  
*DRUGST, ONGL SAX TABL
[6]  
*DRUGST, JAN SIT TABL
[7]  
*DRUGST, VICT LIR INJ
[8]  
*DRUGST, BYETT EX PEN
[9]   Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine [J].
Fabunmi, Rosalind ;
Nielsen, Loretta L. ;
Quimbo, Ralph ;
Schroeder, Brock ;
Misurski, Derek ;
Wintle, Matthew ;
Wade, Ron .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) :777-786
[10]   Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial [J].
Garber, Alan ;
Henry, Robert ;
Ratner, Robert ;
Garcia-Hernandez, Pedro A. ;
Rodriguez-Pattzi, Hiromi ;
Olvera-Alvarez, Israel ;
Hale, Paula M. ;
Zdravkovic, Milan ;
Bode, Bruce .
LANCET, 2009, 373 (9662) :473-481
12